The CHK1 kinase inhibitor prexasertib (LY2606368) shows potent single-agent efficacy in in vitro and in vivo models of castrate-resistant prostate cancerAnn McNulty,Greg Donoho,Jack Dempsey, Adem Abel,Jennifer Stephens,Ricardo Martinez,Damien Gerald,Carole Perruzzi, Marguerita O'Mahony,Christoph Reinhard,Aimee Lin,Wenjuan WuCANCER RESEARCH(2019)引用 0|浏览31暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要